Samuraciclib hydrochloride rofen piconol ClH/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26

ClH/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26

30 min) inhibits the suppression of vascular contractility in response to peroxynitrite in thoracic aortic rings

CAS Number: 229305-39-9

which is a promising target for restricting cancer stem cell and cancer progression

β-alanine significantly increases malignant cell sensitivity to doxorubicin

Samuraciclib hydrochloride rofen piconol ClH/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26Samuraciclib hydrochloride (CT7001 hydrochloride) is a potent, selective, ATP competitive and orally active CDK7 inhibitor, with an IC50 of 41 nM. Samuraciclib hydrochloride displays 45 , 15 , 230 and 30 fold selectivity over CDK1, CDK2 (IC50 of 578 nM), CDK5 and CDK9, respectively. Samuraciclib hydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0. 2 0. 3 M. Samuraciclib hydrochloride has anti tumor effects. Product